|
Market Closed -
Australian S.E.
03:58:07 21/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 0.3650 AUD | -2.67% |
|
-1.35% | -43.85% |
| Market Cap | 112M 79.96M 68.46M 63.87M 58.61M 110M 7.65B 758M 295M 3.83B 300M 294M 12.69B | P/E 2026 * |
-6.15x | P/E 2027 * | -4.41x |
|---|---|---|---|---|---|
| Enterprise Value | 118M 83.69M 71.65M 66.85M 61.34M 115M 8.01B 793M 309M 4.01B 314M 307M 13.29B | EV / Sales 2026 * |
15.1x | EV / Sales 2027 * | 11x |
| Free-Float |
62.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.67% | ||
| 1 week | -1.35% | ||
| Current month | -1.35% | ||
| 1 month | -1.35% | ||
| 3 months | -27.72% | ||
| 6 months | -35.96% | ||
| Current year | -43.85% |
| 1 week | 0.36 |  | 0.38 |
| 1 month | 0.35 | | 0.38 |
| Current year | 0.35 | | 0.73 |
| 1 year | 0.35 | | 0.73 |
| 3 years | 0.28 | | 0.73 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/7/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/7/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/7/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.67% | -1.35% | -14.12% | -48.95% | 79.96M | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,109B | |
| -2.21% | +2.02% | +49.50% | +55.01% | 644B | |
| -1.56% | +4.39% | +25.19% | +74.39% | 463B | |
| -1.30% | +3.24% | +39.66% | +44.16% | 371B | |
| -1.08% | +2.06% | +21.49% | +38.84% | 301B | |
| -0.58% | +4.78% | -0.33% | +12.50% | 256B | |
| -1.95% | +3.80% | +46.31% | +65.66% | 234B | |
| -0.39% | +0.05% | -17.20% | -53.24% | 205B | |
| -2.82% | +3.84% | +20.81% | +89.04% | 178B | |
| Average | -0.72% | +2.70% | +24.77% | +40.51% | 376.11B | |
| Weighted average by Cap. | -0.15% | +3.26% | +42.66% | +69.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.78M 5.54M 4.74M 4.42M 4.06M 7.63M 530M 52.49M 20.46M 266M 20.8M 20.34M 879M | 12.5M 8.9M 7.62M 7.11M 6.52M 12.25M 851M 84.31M 32.87M 427M 33.41M 32.68M 1.41B |
| Net income | -18.29M -13.02M -11.15M -10.4M -9.55M -17.94M -1.25B -123M -48.12M -625M -48.9M -47.84M -2.07B | -25.1M -17.87M -15.3M -14.28M -13.1M -24.61M -1.71B -169M -66.02M -857M -67.1M -65.64M -2.84B |
| Net Debt | 5.24M 3.73M 3.19M 2.98M 2.73M 5.13M 357M 35.32M 13.77M 179M 14M 13.69M 592M | 24.96M 17.77M 15.22M 14.2M 13.03M 24.48M 1.7B 168M 65.66M 852M 66.74M 65.29M 2.82B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | $0.3650 | -2.67% | 230,817 |
| 20/08/26 | $0.3750 | -2.60% | 34,406 |
| 19/08/26 | $0.3850 | +1.32% | 23,226 |
| 18/08/26 | $0.3800 | -1.30% | 13,762 |
| 17/08/26 | $0.3850 | +4.05% | 31,851 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
